BioFlo 45872Recalls & reported problems
Navilyst Medical, Inc. · BioFlo PICC with Endexo Technology - 5F x 55cm Dual Lumen Catheter IR-145 Kit · Class 2 · Implant
All models of BioFlo (87)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI H965458720), received between Aug 17, 2021 and Dec 11, 2024 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Difficult to Remove” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Remove1
- Fluid/Blood Leak1
- Infusion or Flow Problem1
- Stretched1
Patient problems
- Swelling/ Edema2
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 11, 2024Fluid/Blood Leak; Fluid/Blood Leak
A DISTRIBUTOR REPORTED THAT AN END-USER EXPERIENCED AN ISSUE WITH A BIO-STABLE 5F DL-55 CM IR-145 KIT NON-VALVED PICC. 48 HOURS POST PLACEMENT, A LEAK WAS OBSERVED AT THE INSERTION SITE WHEN INFUSING MEDICATION AND FLUIDS. THE PATIENT'S LEFT CUBITAL FOSSA WHERE PICC WAS LOCATED WAS OBSERVED TO SWOLLEN. THE CATHETER WAS REMOVED AND REPLACED DUE TO REDUCED FLOW RATE AT BOTH LUMENS AND WORSENING SWELLING.
Patient problems: Swelling/ Edema
MAUDE report 20901555 ↗MalfunctionApr 19, 2023Stretched; Infusion or Flow Problem; Stretched; Infusion or Flow Problem
DURING THE INSERTION PROCEDURE OF A PICC FROM A BIO-STABLE 5F DL-55CM IR-145 KIT NON-VALVED KIT, UNDER FLUOROSCOPIC AND GUIDE-WIRE ASSISTANCE, THE PROVIDER WAS UNABLE TO RETRIEVE THE CATHETER THAT WAS THREADED OVER THE WIRE. AFTER MULTIPLE MANIPULATIONS, THE GUIDEWIRE WAS ABLE TO BE RETRIEVED, LEAVING THE CATHETER SUCCESSFULLY INSITU. THE NEXT DAY, THE PATIENT PRESENTED WITH A COMPLAINT OF SWELLING AT THE PICC INSERTION SITE AT THE LEFT CUBITAL FOSSA. THE CATHETER WAS THEN REMOVED DUE TO REDUCE FLOW RATE IN BOTH LUMENS AND THE WORSENING SWELLING. IT WAS SUSPECTED CATHETER WAS OVERSTRETCHED OR LEAKING. UPON INSPECTION OF THE REMOVED CATHETER, IT WAS NOTED THE MID-PORTION OF THE CATHETER WAS STRETCHED OUT AND DEFECTIVE.
Patient problems: Swelling/ Edema
MAUDE report 16771837 ↗MalfunctionAug 17, 2021Difficult to Remove; Difficult to Remove
A DISTRIBUTOR REPORTED AN ISSUE THEIR CUSTOMER EXPERIENCED WHEN USING A BIO-STABLE 5F DL-55CM IR-145 KIT NON-VALVED PROCEDURE KIT. IT WAS REPORTED THAT THE PROVIDER WAS PERFORMING THE BIOFLO PICC INSERTION FOR A PEDIATRIC CASE UNDER SEDATION. ACCORDING TO THE END USER, "PEDIATRIC CASES CAN BE CHALLENGING DUE TO SMALL VEINS, BUT IT WAS SMOOTH PUNCTURE FOR THIS CASE INTO THE VEIN. BUT UNEXPECTEDLY, THE CHILD HAD A STENOSIS PROXIMAL TO THE PUNCTURE SITE, WHICH WAS NOT KNOWN ABOUT BEFORE HAND, AND IT DAMAGED THE GUIDE WIRE TIP." AFTER THE TIP OF GUIDE WIRE WAS DAMAGED, THE END USER WAS UNABLE PULL OUT THE WIRE FROM PUNCTURE NEEDLE AS IT STUCK AT NEEDLE TIP. THE PROVIDER HAD TO ABANDON THE ACCESS DUE TO THIS REASON. THE PROVIDER ENDED UP NEEDING TO RE-PUNCTURE ANOTHER VEIN, AND INSERTED THE CATHETER WITH THE AID OF ANOTHER GUIDE WIRE (MICRO-PUNCTURE SET GUIDE WIRE) AS THE TIP OF THE INITIAL WIRE WAS STUCK IN THE 1ST PUNCTURE NEEDLE TIP AND DAMAGED (NON-SALVAGEABLE). THE PHYSICIAN REPORTED TO THE DISTRIBUTOR A CONCERN ABOUT THE PATIENT BEING UNDER EXTENDED CONSCIOUS SEDATION FOR AN ADDITIONAL 45 MINUTES WHILE THE ISSUE WAS RESOLVED. THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS, HAR
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12330925 ↗
Other Catheter,intravascular,therapeutic,long-term greater than 30 days devices
- Groshong NXT ClearVue Catheter 7617405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,708 reports
- Groshong NXT ClearVue Catheter 7655405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,536 reports
- PowerPICC Catheter 3174118Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall402 reports
- L-Cath™ S/L PICC S/L 26GA (1.9F) x 30cmArgon Medical Devices, Inc. · Catheter,Intravascular,Therapeutic,Long-Term Greater Than 30 Days2 recalls245 reports
- PowerPICC SOLO2 Catheter 1194108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 recalls216 reports
- Broviac 0600520Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall265 reports
- Groshong® Catheter 7717405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days279 reports
- PowerPICC Catheter 3275118Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days272 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page